Clover Health Investments, Corp. (CLOV) Financial Statements
Clover Health Investments, Corp. (CLOV) reported trailing twelve-month revenue of $2.5B (up 54.0% year on year) and net income of -$18.4M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $74.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLOVClover Health Investments, Corp.Follow CLOV — free
—
Price chart with a free account
- Market cap
- 2.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 1.47 | 1.10 | 1.26 | 1.37 | 1.92 | 2.48 | |
| Gross profit | -0.08 | 0.02 | 0.26 | — | — | — | |
| Operating income | -0.64 | -0.29 | -0.21 | -0.05 | -0.09 | -0.02 | |
| Pre-tax income | -0.59 | -0.25 | -0.21 | -0.05 | -0.09 | -0.02 | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |
| Net income | -0.59 | -0.34 | -0.21 | -0.04 | -0.09 | -0.02 | |
| Diluted EPS ($) | -1.42 | -0.71 | -0.44 | -0.09 | -0.17 | -0.05 | |
| Diluted shares (bn) | 0.413 | 0.476 | 0.482 | 0.490 | 0.512 | — |
USD billions · SEC XBRL
Clover Health Investments, Corp. — questions
- What is Clover Health Investments, Corp.'s revenue?
- $2.5B over the twelve months to 2026-06-30, up 54.0% year on year, from its 10-Q and 10-K filings.
- What is Clover Health Investments, Corp.'s net income?
- -$18.4M over the twelve months to 2026-06-30.
- What is Clover Health Investments, Corp.'s free cash flow?
- $74.2M over the twelve months to 2026-06-30.
- What are Clover Health Investments, Corp.'s diluted earnings per share?
- $-0.05 over the twelve months to 2026-06-30.
Every figure on this page comes from Clover Health Investments, Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.